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Abstract
Background: Patients with postural tachycardia syndrome often appear depressive and report diminished quality
of life (QOL). In the current study, we first evaluated if the maximal heart rate (HR) increment after standing is
associated with the clinical symptoms in patients with excessive orthostatic tachycardia (OT). Next, we investigated
the correlations among the symptoms of orthostatic intolerance (OI), depression, and health-related QOL in these
patients. Finally we assessed if patients with minimal OI symptoms suffer from depression or diminished QOL.
Methods: We performed a comprehensive questionnaire-based assessment of symptoms in 107 patients with
excessive OT with a ≥ 30 beats/min heart rate increment (or ≥ 40 beats/min in individuals aged between 12 and
19) within 10 min after standing up. An existing orthostatic intolerance questionnaire (OIQ), the Beck depression
inventory-II (BDI-II), and the 36 Item Short-Form Health Survey were completed prior to any treatment. Correlation
analyses among the items of the questionnaires and other parameters were performed. Additionally, patients with
minimal OI symptoms were analysed separately.
Results: The maximal orthostatic HR increment was not associated with the clinical symptoms. The OI symptoms
were significantly correlated with depression and diminished QOL. The BDI-II score demonstrated a positive linear
relationship with total OIQ score (r = 0.516), and both physical and mental component summary scales of SF-36
showed a negative linear relationship with total OIQ score (r = -0.542 and r = -0.440, respectively; all p <0.001).
Some OI symptoms were more strongly associated with depression, and others were more strongly related to
QOL. Chest discomfort and concentration difficulties were the most influential OI symptoms for depression, while
nausea and concentration difficulties were the most influential symptoms for physical and mental QOL, respectively.
Dizziness and headache were the two most common complaints in patients with mild to moderate OI symptoms.
In addition, subjects with minimal OI symptoms also had considerable deterioration in QOL.
Conclusion: The OI symptoms, but not the maximal HR increment, are significantly correlated with depression and
diminished QOL in patients with excessive OT. Therefore, pervasive history taking is important when encountering
patients with excessive OT.
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Background
Postural tachycardia syndrome (POTS) is a clinical
syndrome usually characterized by an excessive incre-
ment of heart rate (HR) upon standing with frequent
symptoms of orthostatic intolerance (OI). A diagnosis
of POTS requires a HR increment ≥ 30 beats/min
(bpm) (or ≥ 40 bpm in individuals aged between 12
and 19) within 10 min after standing from a recum-
bent position, in the absence of orthostatic
hypotension [1]. However, some reports have shown
that a certain portion of healthy individuals experi-
ence a HR increment of ≥ 30 bpm after standing (up
to ~30 %), especially in the morning [2]. Therefore,
symptoms of OI may be crucial for making a diagno-
sis of POTS.
Some studies define POTS as when patients have a >
6-month history of OI symptoms [2–4] while other stud-
ies require only a > 3-month history of symptoms [5–7],
and some studies even do not have criteria for a minimal
disease duration [8–11]. Both 3- and 6-month periods
are fairly arbitrary criterion to indicate a chronic condi-
tion. Moreover, symptoms of POTS range from well-
recognized orthostatic dizziness and palpitation, to less
recognized symptoms, such as fatigue, gastrointestinal
dysfunction, and increased sweating. [12, 13] These less
recognized non-orthostatic symptoms could be
unnoticeable without clinical suspicion.
The prevalence of POTS is estimated at 0.2 % in
the general population [1]; however, the exact preva-
lence remains unknown. POTS is still considered to
be an under-recognized disorder [12], and its clinical
significance is increasing, as it has been reported to
be frequently accompanied by depression [11, 14],
sleep problems [15], chronic fatigue syndrome [16,
17], and diminished quality of life (QOL) [15, 18].
However, it is not known if depression or deterior-
ation of QOL occurs frequently in patients with min-
imal OI symptoms despite excessive orthostatic
tachycardia (OT).
In this study, we hypothesized that each specific
symptom of POTS may have a different clinical sig-
nificance for the assessment of POTS or comorbid
conditions, and patients with minimal OI symptoms
might have depression or deteriorated QOL. There-
fore, we performed a comprehensive questionnaire-
based assessment of OI symptoms, depression and
QOL in patients with excessive OT, including those
with minimal OI symptoms. First, we evaluated if the
maximal HR increment is associated with the severity
of symptoms. Second, we analysed the correlations
among the symptoms of OI, depression, and the
physical and mental components of QOL. Finally, we
assessed if patients with minimal OI symptoms suffer
from depression or deterioration of QOL.
Methods
Participants
Patient with excessive OT were recruited from either
neurology outpatient clinics or the Center for Epi-
lepsy and Autonomic Disorders of the Seoul National
University Hospital. The main causes of admission
were recurrent dizziness, headaches, loss of con-
sciousness, convulsive movements, or other paroxys-
mal symptoms requiring the exclusion of syncope or
seizure disorders for accurate diagnosis. Orthostatic
vital sign (OVS) tests were performed twice in every
patient except for one patient who had one OVS test
and one head-up tilt test. The OVS test was per-
formed as described before.[19] The patients were in
a supine position for ≥ 10 min before the baseline
blood pressure (BP) and HR were measured. After the
baseline measurement, patients stood upright without
support and remained still right beside the bed. The
BP and HR were checked immediately and at 1, 3, 5,
and 10 min after standing. Maximal HR increment
observed in each patient was calculated from the two
OVS tests.
Patients were included when at least one of the tests
met the following criteria: (1) HR increment ≥ 30 bpm
(or ≥ 40 bpm in patients aged between 12 and 19) within
10 min after standing up; (2) absence of orthostatic
hypotension leading to compensatory orthostatic tachy-
cardia; and (3) no overt cause for tachycardia, such as
acute blood loss, hyperthyroidism, prolonged bed rest,
or tachycardia-promoting medications. This study was
approved by the Institutional Review Board of Seoul
National University Hospital (IRB No. H-1401-091-550)
and informed consent was obtained from all individual
participants included in the study.
Questionnaire
All subjects performed three sets of self-report ques-
tionnaires prior to the treatment. The symptoms of
OI were evaluated using a questionnaire (Orthostatic
Intolerance Questionnaire, OIQ) which has been
widely used to assess the symptoms of POTS patients
in previous studies [20–24]. The subjects specified the
presence and frequency of nausea, tremor in hands,
dizziness, palpitation, headache, profuse perspiration,
blurred vision, chest discomfort, lightheadedness, and
concentration difficulties. The frequency of specific
symptoms was marked with a score ranging from 0
to 4, with 0 for never, 1 for once a month, 2 for 2–4
times per month, 3 for 2–7 times per week, and 4 for
more often than once daily. The total symptom score
was calculated by summing the scores of 10
symptoms.
Depression was assessed using the Beck depression
inventory-II (BDI-II), which is a widely used self-report
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inventory with 21 multiple-choice questions (score of 0
to 3 for each question). A total score of 0–13 indicates
minimal depression, 14–19 mild depression, 20–28
moderate depression, and 29–63 severe depression [25].
The 36 Item Short-Form Health Survey (SF-36) was
used to assess the health related QOL [26]. The ques-
tionnaire contains 36 items that yield 8 category scales:
physical functioning, role limitation caused by physical
problems, bodily pain, general health, vitality, social
functioning, role limitations caused by emotional prob-
lems, and mental health. These 8 category scores are
aggregated into two summary scales, the physical
component summary scale (PCS) and the mental
component summary scale (MCS), which are normed
to the population (mean = 50, standard deviation = 10).
Higher score represents better QOL, and lower score
indicates worse QOL.
Statistics
Spearman’s rank correlation coefficient was per-
formed to assess the correlation among variables. R-
squared (r2) values were calculated to assess the
goodness-of-fit for a linear model. To correct the
potential confounding variables, partial correlation
analysis was performed. To compare the mean
among subgroups, a Kruskal-Wallis test was per-
formed. The 95 % confidence interval (CI) was cal-
culated from the sample mean and standard
deviation [27]. Logistic regression analysis was per-
formed to investigate the most influential OI symp-
tom for depression or QOL. Significant depression
was defined as BDI ≥ 14, and significant deterioration
of physical or mental QOL were defined as PCS < 40
or MCS < 40, respectively. Univariate analysis for
basic demographic factors (age, sex, body-mass index
(BMI), maximal HR increment) and OIQ items were per-
formed using T-test. The OIQ variables of p < 0.1 and/or
basic demographic factors were included in the multivari-
ate analysis. Data were collected and analysed using SPSS
22.0.0 for Windows, and values of p < 0.05 were considered
significant.
Results
The maximal orthostatic heart rate increment is not
associated with clinical symptoms
A total of 107 patients (67 females; mean age of 31.1 ±
1.3) were enrolled in this study. The mean BMI of the
patients was 22.3 ± 0.3 (Table 1). In total, the mean value
of maximal HR increment after standing up was 42.8 ±
1.2. The average of the total OIQ, BDI-II, PCS, and
MCS scores were 14.9 ± 0.9, 14.8 ± 0.8, 43.4 ± 0.8, and
39.9 ± 1.1, respectively.
Spearman’s correlation coefficient revealed that the
amount of the orthostatic HR increment was not associ-
ated with any of the OI symptoms, depression, or QOL.
The maximal HR increment did not correlate with either
the OIQ, BDI-II, PCS, or MCS scores (all p > 0.05;
Table 2).
Orthostatic intolerance symptoms significantly correlate
with depression and quality of life
Correlation analyses revealed that total OIQ score
displayed a significant correlation with BDI-II, PCS,
and MCS scores (all p < 0.001; Fig. 1). The BDI-II
score demonstrated a positive linear relationship
with total OIQ score, and both the PCS and MCS
showed a negative linear relationship with total OIQ
score. The strength of the correlation was highest in
BDI-II (r = 0.571), followed by the PCS (r = -0.534)
and MCS (r = -0.436; Table 2).
Table 1 Clinical characteristics of the patients
OIQ Total Score Gender, F(%) Age Height (cm) Weight (kg) BMI Max HR Increment BDI-II PCS MCS
Total (n = 107) 67 (62.6%) 31.1 ± 1.3 166.3 ± 0.9 62.2 ± 1.3 22.3 ± 0.3 42.8 ± 1.2 14.8 ± 0.8 43.4 ± 0.8 39.9 ± 1.1
0–4 (n = 16) 7 (43.8%) 23.6 ± 3.0 169.2 ± 2.3 63.7 ± 2.8 22.2 ± 0.7 46.4 ± 3.0 7.4 ± 1.0 49.6 ± 2.2 46.9 ± 2.6
5–9 (n = 15) 9 (60%) 30.5 ± 2.4 168.8 ± 2.6 65.4 ± 3.9 22.7 ± 0.9 38.9 ± 3.0 10.2 ± 1.6 49.0 ± 1.7 45.4 ± 2.1
10–14 (n = 21) 13 (61.9%) 34.7 ± 4.0 168.5 ± 2.5 64.2 ± 3.6 22.4 ± 0.8 45.9 ± 2.9 13.3 ± 1.9 42.4 ± 1.3 41.0 ± 2.1
15–19 (n = 25) 16 (64%) 32.2 ± 2.3 165.2 ± 1.9 62.2 ± 3.1 22.6 ± 0.8 43.2 ± 2.8 17.2 ± 1.6 42.2 ± 1.3 38.8 ± 1.8
20–24 (n = 17) 14 (82.4%) 33.1 ± 2.3 161.5 ± 1.6 58.4 ± 2.4 22.4 ± 0.8 37.2 ± 1.5 19.1 ± 2.0 40.7 ± 1.5 35.9 ± 1.9
25–29 (n = 4) 4 (100%) 25.3 ± 3.2 160.1 ± 4.5 55.2 ± 4.9 21.4 ± 1.1 42.0 ± 4.6 21.8 ± 2.8 39.3 ± 3.7 29.7 ± 2.0
30–34 (n = 6) 3 (50%) 32.5 ± 6.3 167.8 ± 3.6 60.7 ± 4.3 21.5 ± 1.2 47.7 ± 3.9 21.5 ± 3.5 36.9 ± 2.2 30.1 ± 8.3
35–39 (n = 3) 1 (33.3%) 33.7 ± 8.8 164.9 ± 4.2 57.1 ± 5.4 20.9 ± 1.2 40.0 ± 6.2 21.0 ± 4.9 32.3 ± 6.7 33.5 ± 10.1
P value (Kruskall-Wallis) 0.047 0.211 0.81 0.984 0.1 <0.001* <0.001* <0.001*
The values are the mean ± SEM. The Kruskal-Wallis test was performed to compare the mean among the subgroups
Abbreviations: OIQ orthostatic intolerance questionnaire, F female, BMI body-mass index, HR heart rate, BDI-II Beck depression inventory-II, PCS physical component
summary scale of Short Form 36, MCS mental component summary scale of Short Form 36
* p < 0.01
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On partial correlation analysis, the BDI-II score
displayed a positive linear correlation (r = 0.208, p = 0.029)
with total OIQ score while controlling for PCS and MCS.
PCS (r = -0.432, p < 0.01) and MCS (r = -0.198, p = 0.036)
demonstrated inverse linear correlations with total OIQ
score while controlling for BDI-II.
When the patients were divided into 8 subgroups
according to the OIQ scores, each group showed signifi-
cantly different results on the BDI-II and SF-36 (p <
0.001; Table 1). There was a clear tendency that patients
with a higher OIQ score had a greater BDI-II score and
lower PCS and MCS scores (Fig. 2).
In summary, when the patients experienced more OI
symptoms, they were more depressed and felt greater
deterioration in their QOL.
Particular symptoms may be more useful in screening
patients with POTS
All contents of the OIQ were correlated with depression
(BDI-II) and the physical (PCS) and mental components
(MCS) of QOL, with the exception of a few items
(Table 2). Tremor in hands did not correlate with PCS
or MCS, and profuse perspiration did not correlate with
MCS. Most of the 10 OI symptoms were significantly
correlated with other symptoms except for a few combi-
nations (Additional file 1: Table S1).
Assuming that the cases with a Spearman’s correlation
coefficient r >0.4 indicate a stronger correlation, particu-
lar OI symptoms had a stronger association with BDI-II,
PCS, and MCS scores (Table 2). Concentration difficul-
ties, chest discomfort, palpitation, lightheadedness, and
nausea were the symptoms most strongly associated
with depression (in descending order). Lightheadedness,
dizziness, headache, and concentration difficulties (in
descending order) were strongly related to physical
QOL, while concentration difficulties were strongly asso-
ciated with mental QOL. On multivariate analysis
(Table 3), patients with OIQ score ≥ 20 had significantly
higher risk of having depression (odds ratio (OR)
14.300), diminished physical (OR 13.144) and mental
QOL (OR 10.392) when compared to the patients with
OIQ score <10. Among the OI symptoms, chest discom-
fort (OR 1.717) and concentration difficulties (OR 1.470)
were the most influential symptoms for depression. Nau-
sea (OR 2.501) and concentration difficulties (OR 1.756)
were the most influential symptoms for physical and
mental QOL, respectively (Table 3).
When the patients were categorized into 8 subgroups
according to the OIQ scores, certain symptoms appeared
more frequently in patients with low total OIQ scores
(Table 4, Fig. 3). Dizziness followed by headache were
the two most common complaints in patients with an
OIQ score <20. As the OIQ score increased, patients
Table 2 Correlations among the questionnaire parameters
(n = 107) OIQ Total BDI-II PCS MCS
OIQ Total Score .571** −.534** −.436**
1. Nausea .401** −.379** −.209*
2. Tremor in hands .325** −.157 −.176
3. Dizziness .272** −.462** −.307**
4. Palpitation .426** −.390** −.283**
5. Headache .224* −.434** −.262**
6. Profuse perspiration .272** −.213* −.096
7. Blurred vision .339** −.249** −.248*
8. Chest discomfort .518** −.348** −.399**
9. Lightheadedness .413** −.511** −.335**
10. Concentration difficulties .532** −.404** −.466**
Max HR increase −.081 −.032 .123 .083
Spearman’s correlation coefficient was performed for all patients (n = 107). The
values represent the Spearman’s rho correlation coefficient
Abbreviations: OIQ orthostatic intolerance questionnaire, BDI-II Beck depression
inventory-II, PCS physical component summary scale of Short Form 36, MCS
mental component summary scale of Short Form 36
** p < 0.01, * p < 0.05, Bold: stronger correlation
Fig. 1 Correlation analyses between orthostatic intolerance symptoms and other questionnaire parameters. a The total orthostatic intolerance
questionnaire (OIQ) score showed a significant positive linear correlation with the Beck depression inventory-II (BDI-II) score (p < 0.001). b, c The
total OIQ score displayed a significant inverse linear correlation with the physical component summary scale (PCS) and the mental component
summary scale (MCS) of the 36 Item Short-Form Health Survey (p < 0.001). r2 represents a measure of goodness-of-fit of linear regression
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tended to complain more about lightheadedness, con-
centration difficulties and palpitation. In total, dizziness
and headache were the most frequent symptoms, and
profuse perspiration was the least reported patient
complaint.
Subjects with minimal orthostatic intolerance symptoms
despite excessive orthostatic tachycardia may suffer from
decreased quality of life
For the cut-off value distinguishing minimal and consid-
erable OI symptoms, we chose a total OIQ score of 10.
We regarded patients with OIQ score less than 10 as
patients with minimal OI symptoms. In these subpopu-
lations of patients with low OIQ scores between 0–4
and 5–9, MCS scores were substantially lower (46.9 ± 2.6
and 45.4 ± 2.1, respectively) than normal population,
especially in patients with the OIQ score between 5–9
(MCS score 95 % CI: 41.0–49.8). However, PCS scores
were close to the mean value of the healthy population
(49.6 ± 2.2 and 49.0 ± 1.7, respectively) and BDI-II scores
(7.4 ± 1.0 and 10.2 ± 1.6, respectively) were indicative of
minimal depression (Table 1).
Discussion
To our knowledge, this study is the first to evaluate as-
sociations between specific OI symptoms and depression
or QOL in patients with POTS. The severity of each OI
symptom was significantly associated with depression
and QOL. The total OIQ score revealed a positive linear
relationship with the BDI-II score and an inverse linear
correlation with both PCS and MCS of the SF-36 scale.
Meanwhile, the maximum HR increment after standing
up was not associated with any of the OI symptoms,
depression, or QOL. Certain OI symptoms were more
strongly correlated with depression, and some were
more strongly related to a diminished QOL. Dizziness
and headache were the main complaints of patients with
mild OI symptoms, and lightheadedness, concentration
difficulties, and palpitation were more frequently ob-
served in patients with moderate to severe OI symp-
toms. Patients with minimal OI symptoms also displayed
deterioration of QOL.
Contrary to our expectation, the degree of ortho-
static HR increment was not directly related to clin-
ical symptoms, although excessive OT is the main
clinical feature of POTS. This may have resulted
from the fact that the time of the day when the
OVS tests were performed varied among patients in
our study. Diurnal variability of HR is considered a
normal physiologic phenomenon [28, 29], and more-
over it has been reported that OT is exaggerated in
the morning, both in healthy control and in POTS
patients [2, 19]. As the timing of the OVS test was
not controlled, the orthostatic HR increment could
have failed to reflect the severity of POTS.
Table 3 Multivariate analysis for a significant functional deterioration
(n = 107) Depression Diminished physical QOL Diminished mental QOL
OR 95 % CI P value OR 95 % CI P value OR 95 % CI P value
Total OIQ score a
OIQ scores 0–9 Reference Reference Reference
OIQ scores 10–19 6.190 2.021–18.958 0.001* 3.103 0.748–12.883 0.119 4.686 1.583–13.882 0.005*
OIQ scores ≥20 14.300 4.083–50.078 <0.001* 13.144 3.037–56.891 0.001* 10.392 3.071–35.163 <0.001*
OIQ score items b
Nausea 2.501 1.631–3.834 <0.001*
Chest discomfort 1.717 1.130–2.610 0.011*
Concentration difficulties 1.470 1.027–2.104 0.035* 1.756 1.290–2.389 <0.001*
Abbreviations: OIQ orthostatic intolerance questionnaire, QOL quality of life
a Ordinal regression analysis was performed. Basic demographics (age, sex, body mass index, maximal HR increment) and total OIQ scores were analyzed
b Logistic regression analysis was performed. Basic demographics (age, sex, body mass index, maximal HR increment) and OIQ items with P < 0.1 were analyzed
using the backward Wald elimination method (cutoff P ≥ 0.05). The final OIQ items remained in the models are displayed
*p < 0.05
Fig. 2 Mean values of BDI-II, PCS and MCS scores in subgroups
categorized by total OIQ score. All patients were subcategorized
according to total OIQ scores at intervals of 5 points. The mean
BDI-II score in each group shows a tendency to increase as the
OIQ score increases. The mean PCS and MCS values display a
tendency to decrease as the total OIQ score decreases
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Alternatively, it is possible that the amount of the
HR increment is truly not related to the severity of
clinical symptoms. In any case, our finding implies
that the severity of POTS should not be judged
based on the amount of the HR increment after
standing up.
Meanwhile, the severity of OI symptom was signifi-
cantly correlated with depression and the QOL. As
the OI symptoms increase, patients tend to be more
depressed and feel deterioration in their QOL. The
association between depression and decreased QOL is
already well known in many diseases [30–32]. To ex-
clude the possibility that depression and diminished
QOL are the confounding variables, we performed a
partial correlation analysis. The BDI-II score was sig-
nificantly correlated with the OIQ score after correct-
ing PCS and MCS, and likewise, PCS and MCS were
also fairly related to the OIQ score after correcting
for the BDI-II score. Moreover, on the multivariate
analysis, patients with total OIQ score ≥ 20 had
Fig. 3 Symptoms self-reported by patients subcategorized according to total OIQ score. All patients were subcategorized according to total OIQ
scores at intervals of 5 points. Each point of the decagonal scale represents the mean score of each symptom in the designated subgroup. For
example, in the subgroup of patients with total OIQ score between 15 and 19 (purple line), the mean score of Nausea, Tremor in hands, Dizziness,
and Palpitation was 1.3, 0.7, 2.8, and 1.8, respectively. Dizziness and headache were the two most common symptoms complained of by patients
with an OIQ score < 20. As the OIQ score increased, patients tended to complain more about lightheadedness, concentration difficulties and
palpitation. Profuse perspiration was the least reported patient complaint
Table 4 Mean score of the OIQ items in each subgroup


















1. Nausea 0.1 ± 0.1 0.3 ± 0.2 0.5 ± 0.2 1.3 ± 0.3 1.5 ± 0.3 3.0 ± 0.7 3.0 ± 0.5 3.0 ± 0.6 1.1 ± 0.1
2. Tremor in hands 0.1 ± 0.1 0.5 ± 0.3 0.4 ± 0.2 0.7 ± 0.2 1.2 ± 0.2 3.3 ± 0.3 2.7 ± 0.3 3.7 ± 0.3 0.9 ± 0.1
3. Dizziness 1.1 ± 0.3 1.4 ± 0.2 2.5 ± 0.3 2.8 ± 0.2 3.4 ± 0.2 3.3 ± 0.5 3.8 ± 0.2 4.0 ± 0.0 2.5 ± 0.1
4. Palpitation 0.3 ± 0.1 0.5 ± 0.2 0.9 ± 0.2 1.8 ± 0.2 2.8 ± 0.3 2.5 ± 0.7 3.5 ± 0.2 4.0 ± 0.0 1.5 ± 0.1
5. Headache 0.5 ± 0.2 1.2 ± 0.3 2.3 ± 0.3 2.4 ± 0.2 2.8 ± 0.2 3.3 ± 0.5 4.0 ± 0.0 3.7 ± 0.3 2.2 ± 0.1
6. Profuse perspiration 0.1 ± 0.1 0.1 ± 0.1 0.4 ± 0.2 1.2 ± 0.2 0.6 ± 0.2 0.3 ± 0.3 1.3 ± 0.5 3.0 ± 0.6 0.7 ± 0.1
7. Blurred vision 0.4 ± 0.2 0.6 ± 0.2 0.8 ± 0.2 1.2 ± 0.2 1.9 ± 0.3 1.3 ± 0.8 2.5 ± 0.6 4.0 ± 0.0 1.2 ± 0.1
8. Chest discomfort 0.0 ± 0.0 0.7 ± 0.2 0.6 ± 0.2 1.5 ± 0.2 1.8 ± 0.3 3.0 ± 0.4 3.7 ± 0.2 4.0 ± 0.0 1.3 ± 0.1
9. Lightheadedness 0.2 ± 0.1 0.8 ± 0.2 1.5 ± 0.3 2.3 ± 0.2 2.9 ± 0.2 3.5 ± 0.3 3.8 ± 0.2 4.0 ± 0.0 1.9 ± 0.1
10. Concentration difficulties 0.3 ± 0.1 0.7 ± 0.2 1.4 ± 0.3 2.1 ± 0.2 2.4 ± 0.2 3.5 ± 0.3 4.0 ± 0.0 3.7 ± 0.3 1.7 ± 0.1
OIQ total 3.0 ± 0.3 6.7 ± 0.4 11.3 ± 0.3 17.3 ± 0.3 21.2 ± 0.3 26.8 ± 1.0 32.3 ± 0.8 37.0 ± 1.0 14.9 ± 0.9
The values are demonstrated as the mean ± SEM
The two most common symptoms in each group are displayed in bold characters
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significantly higher risk of having depression and
diminished physical and mental QOL (all OR > 10)
than those with low OIQ scores. POTS patients are
known to be mildly depressed, and their QOL is dete-
riorated [3, 15, 18]; however, here, we demonstrated
that this deterioration is directly related to the OI
symptoms. Although we cannot verify the causal rela-
tionship of OI symptoms and the psycho-behavioural
symptoms, it is important to keep in mind that these
symptoms are associated with each other. It is re-
markable that patients with an OIQ score ≥ 10 dem-
onstrated a mean BDI-II score over 13 and mean
PCS and MCS scores below 42, which represent the
presence of depression and significant impairment of
QOL. We strongly recommend that in patients with
excessive OT and an OIQ score ≥ 10, the clinician
should evaluate the presence of coexisting depression
or decline in QOL, which should be reassessed during
the management of POTS patients. Antidepressants
can be prescribed in severely depressed POTS patients
and treatment of POTS may be continued in patients with
sustained deterioration of QOL. We were not able to
evaluate whether other comorbid conditions of POTS,
such as sleep disturbance [15] or chronic fatigue
syndrome [16], could be potential confounding factors;
therefore, additional studies of this subject are required in
the future.
We identified that some specific symptoms of OI are
strongly correlated with depression and diminished
QOL in POTS patients. Concentration difficulties, chest
discomfort, palpitation, lightheadedness, and nausea
showed the strongest correlations (in descending order)
with depression while lightheadedness, dizziness, head-
ache, and concentration difficulties had the strongest
inverse correlations (in descending order) with the phys-
ical component of QOL. Concentration difficulties also
displayed the strongest inverse correlation with the men-
tal component of QOL. According to the multivariate
analysis, chest discomfort and concentration difficulties
were the most influential OI symptoms for depression,
while nausea and concentration difficulties were the
most influential symptoms for diminished physical and
mental QOL, respectively. Benrud-Larson et al. previ-
ously demonstrated that autonomic symptoms are asso-
ciated with QOL in POTS patients [18]. The orthostatic
intolerance subscale showed the strongest correlation
with PCS (r = -0.45, p < 0.05, Spearman’s correlation
coefficient) but not with MCS of the SF-36 scale, and
other subscales of autonomic symptoms displayed
weaker correlations with QOL. The study used the
Autonomic Symptom Profile [33] to evaluate the severity
of autonomic symptoms. However, this measure consists
of 169 questions, which require a substantial amount of
time to complete the questions and to interpret the
results. Therefore, in the current study, we focused on
specific OI symptoms that can be easily asked to the
patients in the clinic and thus have identified specific
symptoms that are strongly associated with the PCS and
MCS, as well as the BDI-II.
We discovered a pattern of frequently reported OI
symptoms according to the total OIQ scores. Dizziness
and headache were the most common symptoms com-
plained of by patients with mild OI symptoms. Light-
headedness, concentration difficulties, and palpitations
tended to increase in patients suffering from moderate
to severe OI symptoms. We also discovered that profuse
perspiration and blurred vision were not frequently pre-
sented in POTS patients with mild to moderate OI
symptoms. Our data are additionally meaningful because
we evaluated the baseline symptoms of OI, depression
and QOL before the treatment was initiated. Most of the
previous studies on depression and QOL in POTS
patients assessed the patients after the treatment was
begun [15, 18]. Therefore, we believe our data reflect the
natural characteristics of POTS better than other previ-
ous studies. We estimate that the data on specific symp-
toms mentioned above will be highly useful in clinical
practice dealing with POTS patients.
It is notable that, among the patients with exces-
sive OT, even patients with minimal OI symptoms
experienced deterioration in mental components of
QOL. Although POTS patients often have a lower
QOL [15, 18], it is not yet known whether the
diminished QOL was the result of excessive OT or
whether excessive OT occurs more frequently in pa-
tients with diminished QOL. Whether QOL improves
after treatment of OT (e.g., beta-blockers) should be
investigated in the near future to determine the
causal relationship between the two conditions. At
this point, we recommend assessing QOL and mood
symptoms in patients who display excessive OT with-
out significant OI symptoms, as they could be the
underestimated symptoms of POTS.
Conclusions
Our study confirms previous reports on the associ-
ation between POTS and depression or diminished
QOL. Furthermore, we identified that the severity of
OI symptoms, but not the maximal HR increment, is
significantly associated with depression and dimin-
ished QOL. Also, we revealed specific OI symptoms
that have higher clinical significance in assessing
psycho-behavioural aspects of POTS patients. We
recommend clinicians to perform an organized and
detailed history taking about the OI symptoms and
psycho-behavioural symptoms (e.g., depression and
decreased QOL) when assessing patients with exces-
sive OT.
Moon et al. Health and Quality of Life Outcomes  (2016) 14:144 Page 7 of 9
Additional file
Additional file 1: Table S1. Correlations among the questionnaire
parameters (full details). Table S2. Univariate analysis for a significant
functional deterioration. (DOCX 34 kb)
Abbreviations
BDI-II: Beck depression inventory-II; bpm: Beats/minute; CI: Confidence
interval; HR: Heart rate; MCS: Mental component summary scale;
OI: Orthostatic intolerance; OIQ: Orthostatic Intolerance Questionnaire;
OT: Orthostatic tachycardia; OVS: Orthostatic vital sign; PCS: Physical
component summary scale; POTS: Postural tachycardia syndrome;
QOL: Quality of life; SF-36: 36 Item Short-Form Health Survey
Funding
This study was supported by the Korean Health Technology R&D Project of
the Ministry of Health & Welfare, Republic of Korea (HI13C1558) and the
National Research Foundation of Korea (NRF) funded by the Ministry of
Science, ICT & Future Planning (NRF-2016R1C1B2016275). Jangsup Moon was
supported by SK Young Investigator Award by SK chemicals, Korean
Neurological Association.
Availability of data and materials section
The datasets during and/or analysed during the current study available from
the corresponding author on reasonable request.
Authors’ contributions
JM designed the study, interpreted data and drafted the manuscript.
DYK, WJL, HSL, and JSJ conducted data collection. JIB, JSS, and JWS
conducted the data analysis and statistical interpretation. JAL and TJK
helped to draft the manuscript. KIP, KHJ, STL, and KYJ contributed in
the revision and finalization of the manuscript. KC and SKL designed
the study, supervised data collection, and reviewed the manuscript.
All authors read and appoved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
This study was approved by the Institutional Review Board of Seoul National
University Hospital (IRB No. H-1401-091-550) and informed consent was
obtained from all individual participants included in the study.
Author details
1Department of Neurology, Laboratory for Neurotherapeutics,
Comprehensive Epilepsy Center, Center for Medical Innovations, Biomedical
Research Institute, Seoul National University Hospital, Seoul, Republic of
Korea. 2Department of Neurology, Seoul National University Hospital
Healthcare System Gangnam Center, Seoul, Republic of Korea. 3Program in
Neuroscience, Seoul National University College of Medicine, Seoul, Republic
of Korea. 4Department of Neurology, Kyung Hee University Hospital at
Gangdong, Seoul, Republic of Korea. 5Department of Neurology,
Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea.
6Department of Neurology, CHA Bundang Medical Center, CHA University,
Seoungnam, Republic of Korea.
Received: 7 January 2016 Accepted: 30 September 2016
References
1. Sheldon RS, Grubb 2nd B, Olshansky B, Shen W-K, Calkins H, Brignole M,
Raj SR, Krahn AD, Morillo CA, Stewart JM. Heart rhythm society expert
consensus statement on the diagnosis and treatment of postural
tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal
syncope. Heart Rhythm. 2015;12(6):e41–63.
2. Brewster JA, Garland EM, Biaggioni I, Black BK, Ling JF, Shibao CA, Robertson
D, Raj SR. Diurnal variability in orthostatic tachycardia: implications for the
postural tachycardia syndrome. Clin Sci (Lond). 2012;122:25–31.
3. Raj V, Haman KL, Raj SR, Byrne D, Blakely RD, Biaggioni I, Robertson D,
Shelton RC. Psychiatric profile and attention deficits in postural tachycardia
syndrome. J Neurol Neurosurg Psychiatry. 2009;80:339–44.
4. Raj SR, Black BK, Biaggioni I, Harris PA, Robertson D. Acetylcholinesterase
inhibition improves tachycardia in postural tachycardia syndrome.
Circulation. 2005;111:2734–40.
5. Kimpinski K, Figueroa JJ, Singer W, Sletten DM, Iodice V, Sandroni P, Fischer
PR, Opfer-Gehrking TL, Gehrking JA, Low PA. A Prospective, 1-Year Follow-up
Study of Postural Tachycardia Syndrome. Mayo Clin Proc. 2012;87:746–52.
6. Thieben MJ, Sandroni P, Sletten DM, Benrud-Larson LM, Fealey RD, Vernino
S, Low PA, Lennon VA, Shen W-K. Postural orthostatic tachycardia
syndrome: the Mayo clinic experience. Mayo Clin Proc. 2007;82:308–13.
7. Grubb BP. Postural tachycardia syndrome. Circulation. 2008;117:2814–7.
8. Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I,
Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH. Consensus statement on
the definition of orthostatic hypotension, neurally mediated syncope and
the postural tachycardia syndrome. Clin Auton Res. 2011;21:69–72.
9. Sousa A, Lebreiro A, Freitas J, Maciel MJ. Long-term follow-up of patients
with postural tachycardia syndrome. Clin Auton Res. 2012;22:151–3.
10. Fu Q, VanGundy TB, Shibata S, Auchus RJ, Williams GH, Levine BD. Exercise
training versus propranolol in the treatment of the postural orthostatic
tachycardia syndrome. Hypertension. 2011;58:167–75.
11. Lkhagvasuren B, Oka T, Kawai K, Takii M, Kanemitsu Y, Tokunaga S, Kubo C.
Prevalence of postural orthostatic tachycardia syndrome in patients with
psychiatric disorders. Psychother Psychosom. 2011;80:308–9.
12. Pandian J, Dalton K, Henderson R, McCombe P. Postural orthostatic tachycardia
syndrome: an underrecognized disorder. Intern Med J. 2007;37:529–35.
13. Baker J, Kimpinski K. A prospective 1-year study of postural tachycardia and
the relationship to non-postural versus orthostatic symptoms. Physiol Behav.
2015;147:227–32.
14. Benarroch EE. Postural tachycardia syndrome: a heterogeneous and
multifactorial disorder. Mayo Clin Proc. 2012;87:1214–25.
15. Bagai K, Song Y, Ling J, Malow B, Black B, Biaggioni I, Robertson D, Raj S.
Sleep disturbances and diminished quality of life in postural tachycardia
syndrome. J Clin Sleep Med. 2011;7:204.
16. Reynolds G, Lewis D, Richardson A, Lidbury B. Comorbidity of postural
orthostatic tachycardia syndrome (POTS) and chronic fatigue syndrome
(CFS) in an Australian cohort. J Intern Med. 2014;275(4):409–17.
17. Hoad A, Spickett G, Elliott J, Newton J. Postural orthostatic tachycardia
syndrome is an under-recognized condition in chronic fatigue syndrome.
QJM. 2008;101:961–5.
18. Benrud-Larson LM, Dewar MS, Sandroni P, Rummans TA, Haythornthwaite
JA, Low PA. Quality of life in patients with postural tachycardia syndrome.
Mayo Clin Proc. 2002;77:531–7.
19. Moon J, Lee HS, Byun J-I, Sunwoo J-S, Shin J-W, Lim J-A, Kim T-J, Shin Y-W,
Lee K-J, Jeon D. The complexity of diagnosing postural orthostatic
tachycardia syndrome: influence of the diurnal variability. J Am Soc
Hypertens. 2016;10:263–70.
20. Winker R, Barth A, Dorner W, Mayr O, Pilger A, Ivancsits S, Ponocny I, Heider
A, Wolf C, Rüdiger H. Diagnostic management of orthostatic intolerance in
the workplace. Int Arch Occup Environ Health. 2003;76:143–50.
21. Winker R, Barth A, Bidmon D, Ponocny I, Weber M, Mayr O, Robertson
D, Diedrich A, Maier R, Pilger A, et al. Endurance exercise training in
orthostatic intolerance : A randomized, controlled trial. Hypertension.
2005;45:391–8.
22. Yang JY, Zhao J, Du SX, Liu D, Fu CH, Li XY, Chen S, Tang CS, Du JB, Jin HF.
Postural orthostatic tachycardia syndrome with increased erythrocytic
hydrogen sulfide and response to midodrine hydrochloride. J Pediatr. 2013;
163:1169–73.e2.
23. Zhang QY, Liao Y, Tang CS, Du JB, Jin HF. Twenty-four-hour urinary sodium
excretion and postural orthostatic tachycardia syndrome. J Pediatr. 2012;161:
281–4.
24. Zhang F, Li X, Ochs T, Chen L, Liao Y, Tang C, Jin H, Du J.
Midregional pro-adrenomedullin as a predictor for therapeutic
response to midodrine hydrochloride in children with postural
orthostatic tachycardia syndrome. J Am Coll Cardiol. 2012;60:315–20.
25. Beck AT, Steer RA, Ball R, Ranieri WF. Comparison of Beck Depression
Inventories-IA and-II in psychiatric outpatients. J Pers Assess. 1996;67:588–97.
Moon et al. Health and Quality of Life Outcomes  (2016) 14:144 Page 8 of 9
26. Jenkinson C, Coulter A, Wright L. Short form 36 (SF36) health survey
questionnaire: normative data for adults of working age. BMJ. 1993;306:
1437–40.
27. Soper, D.S. Confidence Interval Calculator for the Population Mean
[Software]. 2016. Available from: http://www.danielsoper.com/statcalc.
28. Rubenstein JC, Freher M, Kadish A, Goldberger JJ. Diurnal heart rate patterns
in inappropriate sinus tachycardia. Pacing Clin Electrophysiol. 2010;33:911–9.
29. Richards A, Nicholls M, Espiner E, Ikram H, Cullens M, Hinton D. Diurnal
patterns of blood pressure, heart rate and vasoactive hormones in normal
man. Clin Exp Hypertens A Theory Pract. 1986;8:153.
30. Boylan L, Flint L, Labovitz D, Jackson S, Starner K, Devinsky O. Depression
but not seizure frequency predicts quality of life in treatment-resistant
epilepsy. Neurology. 2004;62:258–61.
31. Amato M, Ponziani G, Rossi F, Liedl C, Stefanile C, Rossi L. Quality of life in
multiple sclerosis: the impact of depression, fatigue and disability. Mult
Scler. 2001;7:340–4.
32. Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and
quality of life a population study. Diabetes Care. 2004;27:1066–70.
33. Suarez G, Opfer-Gehrking T, Offord K, Atkinson E, O’brien P, Low P.
The autonomic symptom profile a new instrument to assess autonomic
symptoms. Neurology. 1999;52:523.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Moon et al. Health and Quality of Life Outcomes  (2016) 14:144 Page 9 of 9
